Cargando…

Irbesartan in experimental diabetic nephropathy

Detalles Bibliográficos
Autores principales: Mahajan, Rajiv, Gupta, Kapil, Singh, Navyug Raj
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937327/
https://www.ncbi.nlm.nih.gov/pubmed/20871777
http://dx.doi.org/10.4103/0253-7613.66849
_version_ 1782186561073315840
author Mahajan, Rajiv
Gupta, Kapil
Singh, Navyug Raj
author_facet Mahajan, Rajiv
Gupta, Kapil
Singh, Navyug Raj
author_sort Mahajan, Rajiv
collection PubMed
description
format Text
id pubmed-2937327
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29373272010-09-24 Irbesartan in experimental diabetic nephropathy Mahajan, Rajiv Gupta, Kapil Singh, Navyug Raj Indian J Pharmacol Letters to Editor Medknow Publications 2010-06 /pmc/articles/PMC2937327/ /pubmed/20871777 http://dx.doi.org/10.4103/0253-7613.66849 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to Editor
Mahajan, Rajiv
Gupta, Kapil
Singh, Navyug Raj
Irbesartan in experimental diabetic nephropathy
title Irbesartan in experimental diabetic nephropathy
title_full Irbesartan in experimental diabetic nephropathy
title_fullStr Irbesartan in experimental diabetic nephropathy
title_full_unstemmed Irbesartan in experimental diabetic nephropathy
title_short Irbesartan in experimental diabetic nephropathy
title_sort irbesartan in experimental diabetic nephropathy
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937327/
https://www.ncbi.nlm.nih.gov/pubmed/20871777
http://dx.doi.org/10.4103/0253-7613.66849
work_keys_str_mv AT mahajanrajiv irbesartaninexperimentaldiabeticnephropathy
AT guptakapil irbesartaninexperimentaldiabeticnephropathy
AT singhnavyugraj irbesartaninexperimentaldiabeticnephropathy